Фармакотерапия острого бронхита

1. Bartlett J, Dowell S, Mandell L et al. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 2000; 31: 347.
2. Wenzel R, Fowler A. Acute Bronchitis. Clinical practice. N Engl J Med 2006; 355: 2125–30.
3. Albert R. Diagnosis and treatment of acute bronchitis. Am Fam Physician 2010; 82 (11): 1345–50. 
4. Синопальников А.И. Острый бронхит у взрослых. Атмосфера. Пульмонология и аллергология. 2005; 3: 15–20. 
5. Worrall G. Acute bronchitis. Can Fam Physician 2008; 54 (2): 238–99.
6. Knutson D, Braun C. Diagnosis and management of acute bronchitis. Am Fam Physician 2002; 65 (10): 2039–44.
7. Wark P. Bronchitis (acute). Clin Evid 2011; p. 1508.
8. www.fcgsen.ru
9. Muñoz F, Carvalho M. Effect of exposure time to PM (10) on emergency admissions for acute bronchitis. Cad Saude Publica 2009; 25 (3): 529–39.
10. Ott S, Rohde G, Lepper P et al. The impact of viruses in lower respiratory tract infections of the adult. Part II: acute bronchitis, acute exacerbated COPD, pneumonia, and influenza. Pneumologie 2010; 64 (1): 18–27.
11. Wadowsky R, Castilla E, Laus S et al. Evaluation of Chlamydia pneumoniae and Mycoplasma pneumoniae as etiologic agents of persistent cough in adolescents and adults. J Clin Microbiol 2002; 40: 637.
12. Slusarcick A, McCaig L. National hospital ambulatory medical care survey: 1998 outpatient department summary. Hyattsville, Md.: U.S. Dept. of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, 2000; DDHS publication no. (PHS) 2000–1250/0–0520.
13. Barlett J. Respiratory Tract Infections. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2001.
14. Зайцев А.А., Кулагина И.Ц., Передельский С.В., Алпенидзе Д.Н. Современные возможности фармакотерапии острого бронхита. Военно-медицинский журнал. 2011; 10 (332): 39–44. 
15. Franck A, Smith R. Antibiotic use for acute upper respiratory tract infections in a veteran population. J Am Pharm Assoc 2010; 50 (6): 726–9.
16. Gonzales R, Bartlett J, Besser R et al. Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background. Ann Intern Med 2001; 134: 521–9.
17. Wark P. Bronchitis (acute). Clin Evid 2011; p.1508.
18. Wenzel R, Fowler A. Acute Bronchitis. Clinical practice. N Engl J Med 2006; 355: 2125–30.
19. Bent S, Saint S, Vittinghoff E, Grady D. Antibiotics in acute bronchitis: a meta-analysis. Am J Med 1999; 107: 62–7.
20. Huang N, Morlock L, Lee C.-H et al. Antibiotic prescribing for children with nasopharyngitis (Common Colds), upper respiratory infections, and bronchitis. Who have health-professional parents. Pediatrics 2005; 116: 4: 826–32.
21. Llor C, Moragas A, Bayona C et al. Effectiveness of anti-inflammatory treatment versus antibiotic therapy and placebo for patients with non-complicated acute bronchitis with purulent sputum. The BAAP Study protocol. BMC Pulm Med 2011; 11: 38–47.
22. Smucny J, Fahey T, Becker L et al. Antibiotics for acute bronchitis. Cochrane Database Syst Rev 2000; 4: 245.
23. Llor C, Cots J. The sale of antibiotics without prescription in pharmacies in Catalonia Spain. Clin Infect Dis 2009; 48 (10): 1345–9.
24. Llor C, Moragas A, Bayona C et al. Effectiveness of anti-inflammatory treatment versus antibiotic therapy and placebo for patients with non-complicated acute bronchitis with purulent sputum. The BAAP Study protocol. BMC Pulm Med 2011; 11: 38–47.
25. Mainous A, Saxena S, Hueston W et al. Ambulatory antibiotic prescribing for acute bronchitis and cough and hospital admissions for respiratory infections: time trends analysis. J R Soc Med 2006; 99 (7): 358–62.
26. Snow V, Mottur-Pilson C, Gonzales R. Principles of appropriate antibiotic use for treatment of acute bronchitis in adults. Ann Intern Med 2001; 134: 518–20. 
27. Recommended composition of influenza virus vaccines for use in the 2008–2009 influenza season. Available at: http:// www.who.int/csr/disease/influenza/recommended_compositionFeb08FullReport.pdf
28. Данные Роспотребнадзора «Об итогах распространения гриппа и ОРВИ в мире и Российской Федерации в эпидсезон 2008–2009 гг. и о прогнозе на эпидсезон 2009–2010 гг.»: http://www.epidemiolog.ru/situation/?ELEMENT_ID=3127
29. Ершов Ф.И., Киселев О.И. Интерфероны и их индукторы (от молекул до лекарств). М.: ГЭОТАР-Медиа, 2005.
30. Jefferson T, Tyrrell D. Antivirals for the common cold. The Cochrane Database of Systematic Reviews 2005; 3: 2743.
31. Малышев Н.А., Колобухина Л.В., Меркулова Л.Н., Ершов Ф.И. Современные подходы к повышению эффективности терапии и профилактики гриппа и других острых респираторных вирусных инфекций. Cons. Med. 2005; 7 (10): 831–5.
32. Eccles R, Morris S, Jawad M. Lack of effect of codeine in the treatment of cough associated with acute upper respiratory tract infection. J Clin Pharmacol Ther 1992; 17: 175–80.
33. Lee P, Jawad M, Eccles R. Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory infection. J Pharm Pharmacol 2000; 52: 1139–42.
34. Schroeder K, Fahey T. Over-the-counter medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev 2008; 1: 1831.
35. Синопальников А.И. Внебольничные инфекции дыхательных путей: диагностика и лечение. М.: М-Вести, 2008; c. 147–65.
36. Hueston W. Albuterol delivered by metered-dose inhaler to treat acute bronchitis. J Fam Pract 1994; 39: 437–40.
37. Smucny J, Flynn C, Becker L, Glazier R. Beta-2-agonists for acute bronchitis. Cochrane Database Syst Rev 2004; 1: 1726.
38. Braman SS. Chronic cough due to acute bronchitis: ACCP evidence-based clinical practice guidelines Chest 2006; 129: 95–103.
39. Fernandes R, Bialy L, Vandermeer B et al. Glucocorticoids for acute viral bronchiolitis in infants and young children. The Cochrane Database Syst Rev 2010; 10: 4878.
40. Wenzel R, Fowler A. Acute Bronchitis. Clinical practice. N Engl J Med 2006; 355: 2125–30.
41. Evrard Y, Kato G, Bodinier MC, Chapelean B. Fenspiride and inflammation in experimental pharmacology. Eur Resp Rev 1991; 1 (Rev. 2): 93–100.
42. Lima MCR, Hatmi M, Martins MA et al. Mediators of inflammation and antagonism of experimental pleurisy in the rat by fenspiride. Rhinology 1988; Suppl. 4: 87–95.
43. Olivieri D, Del Donno M. Efficacy of fenspiride on mucociliary transport. Double-blind with placebo trial. Bull Eur Physiopathol Respir 1987; 23 (Suppl. 12).
44. Pinelli E, Cambon C, Crambes O, Pipy B. Inhibition of LPS-induced TNF-alfa production in mouse inflammatory macrophages by fenspiride. Eur Resp J 1993; 6 (Suppl. 17): 3055–P0776.
45. Плуса Т, Новацка Д. Эффективность и переносимость фенсперида у взрослых больных с острыми респираторными заболеваниями. Лечащий врач. 2000; 1: 51–3.
46. Meza RA. The management of acute bronchitis in general practice results from the Australian morbidity and treatment survey. Aust Fam Physician 1994; 23: 1550–3.
47. Белевский А.С. Возможности оптимизации терапии острых бронхитов на фоне ОРВИ. Лечащий врач. 2001; 8.
48. Козлов В.С., Шиленкова В.В., Чистякова О.Д. Роль воспаления в патогенезе респираторных заболеваний. Cons. Med. 2003; 5 (1).

А.А.Зайцев, И.Ц.Кулагина 

ФГКУ Главный военный клинический госпиталь им. Н.Н.Бурденко Министерства обороны РФ